Skip to main content

Catalyst Biosciences - Chart Of The Day

Revenue for the company previous known as Targacept is expected to grow 103.00% this year and another 125.90% next year.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.